Laboratory Diagnosis of Toxoplasmosis

1. Ashburn, D., Joss, A. W. L., Pennington, T. H., Ho-Yen, D. O. Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of Toxoplasma infecton in pregnancy? J Clin Pathol, 1998, 51, 312-315.

2. Bastien, P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg, 2002, 96, 205-215.

3. Black, M. W., Boothroyd, J. C. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev, 2000, 64, 3, 607-623.

4. Buffolano, W., Lappalainen, M., Hedman, L., Ciccimara, F. et al. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis, 2004, 23, 825-830.

5. Contini, C., Seraceni, S., Cultera, R., Incorvaia, C. et al. Evaluation of a real-time PCR-based assay using the lightcycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from pacients with toxoplasmic retinochoroiditis. Int J Parasitol, 2005, 35, 275-283.

6. Costa, J. M., Dardé, M. L., Assouline, B., Vidaud, M., Bretagne, S. Microsatellite in beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screenining of amniotic fluids. J Clin Microbiol, 1997, 35, 10, 2542-2545.

7. Čatár, G., Červeň, D., Jalili, N.A. Toxoplasma gondii. Bratisl Lek Listy, 1998, 99, 11, 579-583.

8. Čatár, G., Valent, M. Toxoplazmóza a jej význam v pôrodníctve a gynekológii. Prakt Gynek, 1994, 1, 1, 7-10.

9. Čatár, G. Possibilities of vaccination against toxoplasmosis. Klin Mikrobiol Infekc Lek, 1997, 3, 4, 103-105.

10. Delhommeau, F., Forestier, F. Quantification of Toxoplasma gondii in amniotic fluid by rapid cycle real-time PCR. In: Reischl U., Wittwer C., Cockerill F. Rapid cycle real-time PCR-methods and application, Springer Verlag Berlin Heidelberg, 2002, 133-138.

11. Dubey, J. P., Lindsay, D. S., Speer, D. A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev, 1998, 11, 267-299.

12. Fajfrlík, K., Brejchová, H. Zkušenosti s vyšetřováním těhotných žen na přítomnost protilátek proti Toxoplasma gondii. Remedia - Klinická mikrobiologie, 1998, 2, 7, 227-229.

13. Fekkar, A., Bodaghi, B., Touafek, F., Le Hoang, P. et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol, 2008, 46, 6, 1965-1967.

14. Filisetti, D., Gorcii, M., Pernot-Marino, E., Villard, O., Candolfi, E. Diagnosis of congenital toxoplasmosis: Comparison of targets for detection of Toxoplasma gondii by PCR. J Clin Microbiol, 2003, 41, 10, 4826-4828.

15. Flegr, J., Hrdá, Š., Kodym, P. Influence of latent asymptomatic toxoplasmosis on body weight of pregnant women. Folia Parasitol, 2005, 52, 199-204.

16. Flegr, J. Effects of Toxoplasma on human behavior. Schizophr Bull, 2007, 33, 3,757-760.

17. Fuentes, I., Rodriguez, M., Domingo, C. J., Del Castillo, F. et al. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol, 1996, 34, 10, 2368-2371.

18. Gay-Andrieu, F., Marty, P., Pialat, J., Sournies, G. et al. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat Diagn, 2003, 23, 558-560.

19. Goldman, M. Staining Toxoplasma gondii with fluorescein–labeled antibody. I. The reaction in smears of peritoneal exudate. J Exp Med, 1957,105, 549-556.

20. Goldman, M. Staining Toxoplasma gondii with fluorescein–labeled antibody. II. A new serologic test for antibodies to Toxoplasma besed upon inhibition of specific staining. J Exp Med, 1957,105, 557-573.

21. Goldman, M. Staining Toxoplasma gondii with fluorescein–labeled antibody. III. The reaction in frozen and paraffin sections. Am J Clin Pathol, 1959, 32, 159-164.

22. Gross, U., Keksel, O., Dardé, M. L. Value of detecting immunoglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection. Clin Diagn Lab Immunol, 1997, 4, 3, 247-251.

23. Hejlíček, K., Literák, I., Vostalová, E., Křešnička, J. Protilátky proti Toxoplasma gondii u gravidních žen v okrese České Budějovice. Epidemiol Mikrobiol Imunol, 1999, 48, 3, 102-105.

24. Hohlfeld, P., Daffos, F., Costa, J. M., Thulliez, P. et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N Engl J Med, 1994, 331, 11, 695-699.

25. Hübner, J., Uhlíková, M. Use of the microprecipitation in agar gel (MPA) method in the diagnostics of toxoplasmosis. I. Serological animal tests in isolation experiments using MPA. J Hyg Epidemiol Microbiol Immunol, 1969, 13, 4, 514-520.

26. Hutchison, W. M., Dunachie, J. F., Siim, J. C., Work, K. Life cycle of Toxoplasma gondii. Br Med J, 1969, 4, 5686, 806.

27. Hutchison, W. M., Dunachie, J. F., Work, K., Siim, J. C. The life cycle of the coccidian parasite, Toxoplasma gondii, in the domestic cat. Trans R Soc Trop Med Hyg, 1971, 65, 3, 380-399.

28. Hutchison, W. M. Experimental transmission of Toxoplasma gondii. Nature, 1965, 4, 987, 961-962.

29. Chabbert, E., Lachaud, L., Crobu, L., Bastien, P. Comparison of two widely used PCR primer system for detection of Toxoplasma in amniotic fluid, blood, and tissues. J Clin Microbiol, 2004, 42, 4, 1719-1722.

30. Chapman, D. J., Ashburn, D., Ogston, S. A., Ho-Yen, D. O. The relatioship between ocular toxoplasmosis and levels of specific Toxoplasma antibodies. Epidemiol Infect, 1999, 122, 299-303.

31. Janků, J. Pathogenesa a patotlogická anatomie tak nazvaného vrozeného kolobomu žluté skvrny v oku normálně velikém, mikropthalmickém s nálezem parazitu v sítnici. Čas Lek Čes, 1923, 39-43, 1021-1027, 1054-1059, 1081-1085, 1111-1115, 1138-1143.

32. Jíra, J., Bozděch, V. Complement fixation reaction in toxoplasmosis. I. Basic method with antigen from moise ascites. Čas Lek Česk., 1957, 96, 44, 1396-1401.

33. Jongert, E., De Craeye, S., Dewit, J., Huygen, K. GRA7 provides protective imunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol, 2007, 29, 445-453.

34. Kaňková, Š., Šulc, J., Nouzová, K., Fajfrlík, K. et al. Women infected with parasite Toxoplasma have more sons. Naturwissenschaften, 2007, 94, 2, 122-127.

35. Kodym, P., Malý, M., Švandová, E., Ležatková, H. et al. Toxoplasma in the Czech Republic 1923-1999: first case to widespread outbreak. In: Petersen E., Pollak A., Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol, 2001, 31, 115-144.

36. Kodym, P., Tolarová, V. Laboratorní diagnostika toxoplazmózy. Remedia- Klinická mikrobiologie, 1998, 2, 7, 224-226.

37. Kouba, K., Jíra, J., Hübner, J. Toxoplazmóza. 1. vyd. Praha: Avicenum, 1974. 312 s.

38. Lappalainen, M., Koskela, P., Koskiniemi, M., Ämmälä, P. et al. Toxoplasmosis aquired during pregnancy: Impruved serodiagnosis based on avidity of IgG. J Infect Dis, 1993, 167, 691-697.

39. Lindová, J., Novotná, M., Havlícek, J., Jozífková, E. et al. Gender differences in behavioural changes induced by latent toxoplasmosis. Int J Parasitol, 2006, 36, 14, 1485-1492.

40. Lüder, C. G., Gross, U. Toxoplasmosis: from clinics to basic science. Parasitol Today, 1998, 14, 2, 43-45.

41. Maďarová, L., Klement C. Využitie molekulárno-biologických metód v mikrobiologických laboratóriách verejného zdravotníctva I. Hygiena, 2006, 51, 3-4, 110-115.

42. Maďarová, L. Využitie molekulárno-biologických metód v mikrobiologických laboratóriách verejného zdravotníctva II. Laboratórna diagnostika vybraných druhov agens – Bordetella pertussis, Bacillus antracis, Toxoplasma gondii. Hygiena, 2007, 52, 4, 118-125.

43. Machala, L., Kodym, P., Rozsypal, H, Staňková, M., Sedláček, D. Doporučený postup diagnostiky a terapie toxoplazmózy u osob s HIV infekcí. Klin Mikrobiol Infekc Lek, 2007, 13, 6, 248-252.

44. Mechain, B., Garin, Y. J., Robert-Gangneux, F., Dupouy-Camet, J., Derouin, F. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin Diagn Lab Immunol, 2000, 7, 4, 703-705.

45. Mei-Hui Lin, Tse-Ching Chen, Tseng-Tong Kuo, Ching-Chung Tseng, Ching-Ping Tseng. Real-Time PCR for quantitative detection of Toxoplasma gondii. J Clin Microbiol, 2000, 38, 11, 4121-4125.

46. Montoya, J. G., Remington, J. S. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis, 1996, 23, 277-282.

47. Montoya, J. G. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis, 2002, 185, 73-82.

48. Mullis, K. B, Faloona, F. A. Specific synthesis of DNA in vitro via a Polymerase chain reaction, Methods Enzymol, 1987, 155, 335-350.

49. Odborné usmernenie Ministerstva zdravotníctva Slovenskej republiky o diagnostike toxoplazmózy. Vestník MZ SR, 2006, čiastka 52-53, ročník 54, 406-410.

50. Ondriska, F., Čatár, G., Vozárová, G. The significance of complement fixation test in clinical diagnosis of toxoplasmosis. Bratisl Lek Listy, 2003, 104, 6, 189-196.

51. Ondriska, F., Jalili, N., Čatár, G. The diagnostic procedures in toxoplasmosis. Bratisl Lek Listy, 2000, 101, 5, 294-301.

52. Ondriska, F., Vozárová, G., Ondrušková, M. Hodnota dôkazu IgE protilátok v diagnostike toxoplazmózy. Lek Obz, 2003, 52, 50-56.

53. Ondriska, F., Vozárová, G., Šišák, M., Hoffman, J. et al. Hodnota Western-blotu pre klinickú diagnostiku toxoplazmózy. Prakt Gynek, 2004, 11, 2, 69-76.

54. Pinon, J. M., Toubas, D., Marx, C., Mougeot, G. et al. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol, 1990, 28, 8, 1739-1743.

55. Plotkin, S. A., Orenstein, W. A. Vaccines, 4th edition, Elsevier Inc., 2004, 1291-1295.

56. Pokorný, J., Fruhbauer, Z., Čuřík, B., Zástěra, M. A tween-ether preparation of Toxoplasma gondii antigen for the complement fixation test. Bull World Health Organ, 1972, 46, 1, 127-130.

57. Remington, J. S., Thulliez, P., Montoya, J. G. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol, 2004, 42, 3, 941-945.

58. Rilling, V., Dietz, K., Krczal, D., Knotek, F., Enders, G. Evaluation of a commercial IgG/IgM western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis, , 2003, 22, 174-180.

59. Robert-Gangneux, F., Gavinet, M. F., Ancelle, T., Raymond, J. et al. Value of prenatal diagnosis of congenital toxoplasmosis: Retrospective study of 110 cases. J Clin Microbiol, 1999, 37, 9, 2893-2898.

60. Romand, S., Wallon, M., Franck, J., Thulliez, P. et al. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol, 2001, 97, 2, 296-300.

61. Sabin, A. B., Feldman, H. A. Dyes as microchemical indicators of a new imunity phenomen affecting a protozoan parasite (Toxoplasma). Science, 1948, 108, 660-663.

62. Sabin, A. B. Toxoplasmic encephalitis in children. J Am Med Assoc, 1941, 116, 807-814.

63. Siim, J. C. Acquired toxoplasmosis; report of 7 cases with strongly positive serologic reactions. J Am Med Assoc, 1951, 147, 17, 1641-1645.

64. Siim, J. C. Studies on acquired toxoplasmosis. II. Report of a case with pathological changes in a lymph node removed at biopsy. Acta Pathol Microbiol Scand, 1952, 30, 1, 104-108.

65. Skallová, A., Kodym, P., Frynta, D., Flegr, J. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology, 2006, 133, 5, 525-535.

66. Splendore, A. Un nuovo protozoa parassita dei conigli. Incontrato nelle lesioni anatomiche d’una malattia che ricorda in molti punti il Kala-azar dell’uomo. Rev Soc Sci Sčo Paulo, 1908, 3, 109-112.

67. Stroehle, A., Schmid, K., Heinzer, I., Naguleswaran, A., Hemphill, A. Performance of western immunoblot assay to detect specifi anti-Toxoplasma gondii IgG antibodies in human saliva. J Parasitol, 2005, 91, 3, 561-563.

68. Studeničová, C., Benčaiová, G., Holková, R. Seroprevalence of Toxoplasma gondii antibodies in healthy population from Slovakia. Eur J Intern Med, 2006, 17, 470-473.

69. Tenter, A. M., Heckeroth, A. R., Weiss, L. M. Toxoplasma gondii from animals to humans. Int J Parasitol, 2000, 30, 1217-1258.

70. Villard, O., Filisetti, D., Roch-Deries, F., Garweg, J. et al. Comparison of Emzyme-Linked Immunosorbent Assay, Immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol, 2003, 41, 8, 3537-3541.

71. Villena, I., Aubert, D., Brodard, V., Quereux, C. et al. Detection of specific immunogliobulin E during maternal, fetal, and congenital toxoplasmosis. J Clin Microbiol, 1999, 37, 11, 3487-3490.

72. Walker, M., Zunt, J. R. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis, 2005, 40, 1005-1015.

73. Wolf, A., Cowen, D., Paige, B. H. Toxoplasmic encephalomyelitis III. A new case of granulomatous encephalitis due to a protozoon. Am J Pathol, 1939, 15, 657-694.

74. Wong, S. Y., Hajdu, M. P., Ramirez, R., Thulliez, P. et al. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol, 1993, 31, 11, 2952-2959.

75. Woznicová, V. Avidita imunoglobulinů G u infekčných onemocnění. Epidemiol Mikrobiol Imunol, 2004, 53, 1, 4-11.

76. Yamamoto, Y. I., Mineo, J. R., Meneghisse, C. S., Gumaraes, A. C. S. Detection in human sera of IgG, IgM and IgA to excreted/secreted antigens from Toxoplasma gondii by use of dot-ELISA and immunoblot assay. Ann Trop Med Parasitol, 1998, 92, 23-30.

77. Zástěra, M., Pokorný, J., Jíra, J., Valkoun, A. Doplněk standardních metodik laboratorní diagnostiky toxoplasmózy. Acta Hyg Epidemiol Microbiol, Príloha č.3/1987, Institut hygieny a epidemiologie Praha, 1986.